COMPLETED

A Single-arm Study Evaluating the Effectiveness and Safety of Suzetrigine (SUZ) for Acute Pain After Selected Surgeries

Talk to us

Conditions

Acute Pain

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this study is to evaluate the effectiveness, safety, and tolerability of SUZ for acute pain after laparoscopic procedures of the intraperitoneal or retroperitoneal cavities or arthroscopic orthopedic procedures.

Official Title

A Phase 4, Open-label, Single-arm Study Evaluating the Effectiveness and Safety of Suzetrigine As Part of Multimodal Therapy for Acute Pain After Laparoscopic Procedures of the Intraperitoneal or Retroperitoneal Cavities or Arthroscopic Orthopedic Procedures

Quick Facts

Study Start:2025-03-27
Study Completion:2025-11-10
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:COMPLETED

Study ID

NCT06887959

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Body mass index (BMI) of greater than or equal to (≥) 18.0 to less than or equal to (≤) 40.0 kilogram per meter square (kg/m\^2)
  2. * Scheduled to undergo a procedure that is in one of the following categories that would typically be treated with opioid therapy for at least 72 hours postoperatively such as
  3. * Laparoscopic intraperitoneal or retroperitoneal procedure
  4. * Arthroscopic orthopedic procedure
  1. Pregnancy or breastfeeding
  2. Severe psychiatric disorders
  3. Active substance abuse
  4. Unstable medical conditions
  5. Inability to comply with study requirements

Contacts and Locations

Study Locations (Sites)

Scottsdale Clinical Trials
Scottsdale, Arizona, 85260
United States
Woodland International Research Group
Little Rock, Arkansas, 72211
United States
Gulfcoast Research Institute
Sarasota, Florida, 34232
United States
MedStar
Baltimore, Maryland, 21218
United States
Oasis Clinical Research
Las Vegas, Nevada, 89121
United States
Cooper University HealthCare (CUH)
Camden, New Jersey, 08103
United States
North Shore University Hospital - Anesthesiology
Manhasset, New York, 11030
United States
OrthoCarolina - Hip & Knee Center
Charlotte, North Carolina, 28207
United States
Eximia Research-Durham
Durham, North Carolina, 27704
United States
Duke University Hospital - Anesthesiology
Durham, North Carolina, 27710
United States
West Clinical Research
Morehead City, North Carolina, 28557
United States
Seaside Clinical Research Institute
Wilmington, North Carolina, 28412
United States
UH Cleveland Medical Center - Anesthesiology
Cleveland, Ohio, 44106
United States
University of Tennessee Medical Center - Anethesiology
Knoxville, Tennessee, 37920
United States
HD Research LLC | First Surgical Hospital
Bellaire, Texas, 77401
United States
Memorial Hermann Village
Houston, Texas, 77043
United States
Tidewater Clinical Research
Norfolk, Virginia, 23502
United States

Collaborators and Investigators

Sponsor: Vertex Pharmaceuticals Incorporated

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-03-27
Study Completion Date2025-11-10

Study Record Updates

Study Start Date2025-03-27
Study Completion Date2025-11-10

Terms related to this study

Additional Relevant MeSH Terms

  • Acute Pain